Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.

The Quick Take
For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to MarketWatch.


